Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

BACKGROUND AND OBJECTIVE A Bayesian belief network (BBN), as diagnostic decision support system, enables the processing of our knowledge of histopathology expressed in descriptive terms, words and concepts. The aim of this study was to evaluate the contribution of a BBN in the improvement of inter-observer agreement and certainty level in the diagnosis and grading of papillary urothelial neoplasms. MATERIALS Inter-observer agreement and certainty level were investigated on 40 cases of non-invasive papillary urothelial neoplasms subdivided according to the WHO 1973 classification. There were 10 urothelial papillomas (UPs), 10 grade 1 papillary carcinomas (G1), 10 grade 2 papillary carcinomas (G2) and 10 grade 3 papillary carcinomas (G3). Five consecutive sessions were held with three observers (RMa, PC and MSt). Sessions A, B and D were based on the morphological evaluation of the specimens with a conventional light microscope only. In sessions C and E, a BBN was used in addition to the microscope. The BBN output was represented by four belief values for four possible diagnostic outcomes. These values ranged from 0.0 to 1.0, with the sum of the belief values being 1.0. Concerning the certainty level, a two-tier system of assessment was adopted in sessions A, B and D: certain versus less certain. In sessions C and E, a belief value equal to or greater than 0.65 was considered as equivalent to "certain". RESULTS In session A, an all-encompassing or synthetic approach to decision-making was adopted. Agreement with the gold standard was seen in 60% (RMa), 55% (PC) and 65% (MSt) of cases, respectively. The level of subjective confidence was "certain" in 35%, 40% and 35% of cases, respectively. Better agreement-70% (RMa), 68% (PC) and 72% (MSt) of cases-was present in session B where an analytical approach based on the evaluation of a series of morphological features was used. The level of subjective confidence was "certain" in 45%, 50% and 55% of cases, respectively. In session C, where a BBN was utilised, a further increase in degree of agreement with the gold standard was observed, e.g. 85% (RMa), 80% (PC) and 86% (MSt) of cases, respectively. Levels of certainty or belief values were high. Decrease in both the level of agreement-60% (RMa), 62% (PC) and 65% (MSt) of cases-and certainty was seen in session D where the observers were left free to evaluate the cases morphologically without the constrain of either a synthetic or analytical approach. In session E, where the BBN was used again, the percentage of cases in agreement with the gold standard increased to 83% (RMa), 81% (PC) and 84% (MSt), respectively. Increase in certainty or belief was also seen. The difference of the results obtained in the sessions A, B and D with those seen in the BBN-based sessions (C and E) is statistically significant. CONCLUSIONS Conventional morphological evaluation of papillary urothelial neoplasms is affected by inter-observer variability and, in many instances, by diagnostic uncertainty. The greatest difficulties are found with G1 and G2 cases. Improvement in inter-observer agreement and certainty level can be achieved with a BBN.

[1]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[2]  S. Krüger,et al.  Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. , 1995, British journal of urology.

[3]  R. Dodge,et al.  Clinical variables which serve as predictors of cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate , 1994, Cancer.

[4]  N. Hamajima,et al.  Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course. , 1991, Nagoya journal of medical science.

[5]  W. Murphy,et al.  Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? , 1987, Cancer.

[6]  P H Bartels,et al.  Prostatic intraepithelial neoplasia (PIN). Performance of bayesian belief network for diagnosis and grading , 1995, The Journal of pathology.

[7]  P H Bartels,et al.  Diagnostic and prognostic decision support systems. , 1995, Pathologica.

[8]  B. Norlén,et al.  Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. , 2010, Scandinavian journal of urology and nephrology.

[9]  F. Freiha,et al.  Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. , 1991, The Journal of urology.

[10]  P. Bartels,et al.  Expert system support using Bayesian belief networks in the diagnosis of fine needle aspiration biopsy specimens of the breast. , 1994, Journal of clinical pathology.

[11]  N. Christensen,et al.  Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description. , 1991, The Journal of urology.

[12]  F. Debruyne,et al.  Grading in superficial bladder cancer. (1). Morphological criteria. , 1988, British journal of urology.

[13]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[14]  E Bengtsson,et al.  Grading of transitional cell bladder carcinoma by image analysis of histological sections. , 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[15]  M. Garnick Tumors of the urinary tract. , 1992, The Western journal of medicine.

[16]  K. Jauhiainen,et al.  Prognostic factors in nodular transitional cell bladder tumours. , 1993, Scandinavian journal of urology and nephrology.

[17]  P H Bartels,et al.  Clinical applications of Bayesian belief networks in pathology. , 1995, Pathologica.

[18]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[19]  P H Bartels,et al.  Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma. , 1996, Human pathology.

[20]  G. Jakse,et al.  Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? , 1987, The Journal of urology.

[21]  P H Bartels,et al.  Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading. , 1994, Analytical and quantitative cytology and histology.

[22]  W. Murphy ASCP survey on anatomic pathology examination of the urinary bladder. , 1994, American journal of clinical pathology.

[23]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[24]  J. Baak Manual of quantitative pathology in cancer diagnosis and prognosis , 1991 .

[25]  J. Webb The Histopathology of Bladder Cancer , 1985 .

[26]  M. Tsutsumi,et al.  Analysis by Step Sectioning of Early Invasive Bladder Cancer with Special Reference to G3·pT1 Disease , 1992, Japanese journal of cancer research : Gann.

[27]  P. Bartels,et al.  Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia , 2002, The Journal of pathology.

[28]  A. López-Beltran,et al.  Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. , 1996, Pathology, research and practice.